share_log

益佰制药(600594.SH)发一季度业绩，净亏损6845.48万元

Yibai Pharmaceuticals (600594.SH) reported first-quarter results with a net loss of 684.548 million yuan

Zhitong Finance ·  Apr 18 20:27

Yibai Pharmaceutical (600594.SH) released its report for the first quarter of 2024. The company achieved operating revenue during the reporting period...

According to Zhitong Finance App News, Yibai Pharmaceutical (600594.SH) released its report for the first quarter of 2024. During the reporting period, the company achieved operating income of 573 million yuan, a year-on-year decrease of 16.26%; net loss attributable to shareholders of listed companies was 684.548 million yuan; net loss attributable to shareholders of listed companies deducted 707.93 million yuan for non-recurring profit and loss; basic loss per share was 0.086 yuan/share.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment